Investigational Agent Shows Benefit in Myasthenia Gravis
(MedPage Today) -- The investigational monoclonal antibody batoclimab led to significant improvement in activities of daily living in people with generalized myasthenia gravis (gMG), a multicenter phase III trial found.
The rate of sustained improvement...
Source: MedPage Today Neurology - Category: Neurology Source Type: news